An exploratory transcriptomic investigation published in BMC Nephrology reported that the frequency of regulated alternative splicing events increases across advancing stages of chronic kidney disease. Researchers sought to characterize renal tissue alternative splicing patterns and the expression of associated RNA-binding proteins across severity groups defined by estimated glomerular filtration rate. The team evaluated these molecular features to clarify progressive stage-dependent changes in kidney tissue and to prioritize candidate targets for subsequent mechanistic investigations.
To investigate these molecular mechanisms across clinical stages, investigators analyzed existing renal tissue RNA-sequencing data obtained from twenty patients with chronic kidney disease under accession GSE137570. The patient samples were classified into four distinct severity categories consisting of normal, mild, moderate, and severe stages based on estimated glomerular filtration rate measurements. The computational workflow combined multiple analytical methods, including K-means clustering, single-sample Gene Set Enrichment Analysis, Weighted Gene Co-expression Network Analysis, and co-expression analysis between RNA-binding proteins and regulated alternative splicing events.
To determine cell-type-specific patterns, the study examined an independent single-cell RNA-sequencing dataset recorded under accession GSE199711. Experimental laboratory evaluations were conducted alongside computational analyses to test splicing and expression patterns across diverse biological systems. The team performed junction-specific reverse transcription quantitative polymerase chain reaction on human peripheral blood mononuclear cells and on renal tissues collected from a rat five-sixths nephrectomy disease model. Histological staining and immunohistochemistry were also conducted to evaluate pathological changes and the spatial distribution of target proteins in rat kidney tissue sections.
The computational analysis established that the overall count of regulated alternative splicing events expanded alongside advancing disease severity. When evaluating 689 dominant-transcript regulated alternative splicing events, the authors classified the observed shifts into six stage-related clusters. Specific clusters were enriched in nuclear factor kappa B signaling. Within that inflammatory pathway, abnormal splicing of NLRP6, CASP8, and CFLAR was detectable at early disease stages. Furthermore, regulated alternative splicing events affecting FYN and IL32 were associated with inferred changes in renal cell composition across the analyzed tissues.
The profiling also identified key RNA-binding proteins displaying marked stage-dependent expression changes across estimated glomerular filtration rate categories. Expression levels of SAMD4A and VIM increased steadily as kidney function declined. Regulated alternative splicing events associated with these specific RNA-binding proteins were functionally enriched in purine nucleotide biosynthesis, a metabolic pathway linked to chronic kidney disease progression. Single-cell RNA-sequencing analysis resolved the elevated expression of VIM specifically to renal tubules, endothelial cells, and leukocytes within the diseased kidney tissue microenvironment.
Laboratory validation confirmed several computational predictions across human blood cells and animal model tissues. Junction-specific reverse transcription quantitative polymerase chain reaction assays using human peripheral blood mononuclear cells verified the splicing ratios of CFLAR, NLRP6, CASP8, and FYN, along with altered expression levels of VIM. In kidney tissues harvested from the rat five-sixths nephrectomy model, assays confirmed matching expression and splicing shifts for key genes including CFLAR, FYN, VIM, and SAMD4A. Immunohistochemistry further demonstrated ectopic expression of VIM and upregulation of SAMD4A in renal tubular epithelial cells of nephrectomized rats, aligning with the single-cell transcriptomic dataset.
The authors concluded that progressing chronic kidney disease involves an increasing burden of abnormal regulated alternative splicing events alongside enrichment of key RNA-binding proteins in the inflammatory microenvironment. Specifically, VIM and SAMD4A become enriched in damaged kidneys and remain closely linked to inflammation-associated splicing events involving CFLAR and FYN. The authors highlighted that their study provides an exploratory framework rather than definitive outcomes, concluding that these findings motivate future cell-type-resolved, statistically confirmatory, and matched-tissue investigations.
Subject of Research: The study characterizes renal tissue-level alternative splicing patterns and the expression of RNA-binding proteins across chronic kidney disease stages.
Article Title: Regulatory networks of alternative splicing and RNA-binding proteins across different stages of chronic kidney disease
Article References: Zhang, S., Xu, C., Guo, X., & Wang, L. (2026). Regulatory networks of alternative splicing and RNA-binding proteins across different stages of chronic kidney disease. BMC Nephrology. https://doi.org/10.1186/s12882-026-05518-4
Image Credits: AI Generated
DOI: 10.1186/s12882-026-05518-4
Keywords: Chronic Kidney Disease, Alternative Splicing, RNA-Binding Proteins, Transcriptomics, eGFR, Renal Physiology, Nephrology, Molecular Mechanisms, Gene Expression, RNA-Seq, NLRP6, CASP8, CFLAR, VIM, SAMD4A, Inflammation, Purine Nucleotide Biosynthesis, Renal Tubular Epithelial Cells
News Source: Jerry Hayes. (November 19, 2026). RNA Splicing Networks Shift Progressively During Chronic Kidney Disease Development. Scienmag.



